Comprehensive Analysis of Equid Herpesvirus Recombination: An Insight Into the Repeat Regions.

Alphaherpesvirus Equid herpesvirus Homologous recombination Infected cell protein 4

Journal

Journal of equine veterinary science
ISSN: 0737-0806
Titre abrégé: J Equine Vet Sci
Pays: United States
ID NLM: 8216840

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 21 06 2023
revised: 25 08 2023
accepted: 05 09 2023
pubmed: 14 9 2023
medline: 14 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

High-throughput sequencing of genomes has expanded our knowledge of the Alphaherpesvirinae, a widely extended subfamily of DNA viruses that recombine to increase their genetic diversity. It has been acknowledged that equid herpesvirus 1 (EHV-1) and equid herpesvirus 4 (EHV-4), two alphaherpesviruses with an economic impact on the horse industry, can recombine. This work aimed to analyze interspecific recombination between all equid alphaherpesvirus species, using genomes of EHV-1, EHV-3, EHV-4, EHV-6, EHV-8, and EHV-9 available in GenBank. 14 events of recombination by RDP4 and Simplot between EHV-1 x EHV-4, EHV-1 x EHV-9, EHV-8 x EHV-1, and EHV-8 x EHV-9 were identified. Ten out of 14 events involved ORF64, a double-copy gene located at the repeat regions that codifies for the infected cell protein 4 (ICP4). Among the ICP4, recombination can be found between EHV-1 X EHV-9, EHV-8 X EHV-9, and EHV-1 X EHV-4, the former affects zebra-borne genotypes, a type of EHV-1 that infect wild equids, and the latter match with previous breakpoints reported in fields isolates. Consequently, these findings strongly suggest that ICP4 is a hotspot for recombination. This work describes novel recombination events and is the first genome-wide recombination analysis using all available equid alphaherpesvirus species genomes.

Identifiants

pubmed: 37704182
pii: S0737-0806(23)00732-3
doi: 10.1016/j.jevs.2023.104916
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104916

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rocío Lucía Tau (RL)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina. Electronic address: tau.rocio@inta.gob.ar.

Carola Ferreccio (C)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina; Chair of immunology, University of Salvador (USAL), Champagnat 1599, CP 1630, Pilar, Buenos Aires, Argentina.

Natalia Bachir (N)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina.

Fatima Torales (F)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina.

Sonia Alejandra Romera (SA)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina; Chair of immunology, University of Salvador (USAL), Champagnat 1599, CP 1630, Pilar, Buenos Aires, Argentina.

Silvina Soledad Maidana (SS)

Institute of Virology and Technological Innovations, IVIT (INTA-CONICET), Dr Nicolas Repetto and De los Reseros, CP 1686, Hurlingham, Buenos Aires, Argentina; Chair of immunology, University of Salvador (USAL), Champagnat 1599, CP 1630, Pilar, Buenos Aires, Argentina.

Classifications MeSH